Rituximab (500mg)
Cytomab 500 mg Injection is used in the treatment of non-Hodgkin lymphoma (NHL), blood cancer (Chronic lymphocytic leukemia) and rheumatoid arthritis.
1 ml in 1 vial
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Cytomab 500 mg Injection is a monoclonal antibody that specifically binds to receptors on cancer cells. Thus it flags the cancer cells for destruction by the body"s immune system.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Cytomab 500 mg Injection may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Cytomab 500 mg Injection is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
It is not known whether Cytomab 500 mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Cytomab 500 mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Cytomab 500 mg Injection may not be needed in these patients. Please consult your doctor.
There is limited information available on the use of Cytomab 500 mg Injection in patients with liver disease. Please consult your doctor.
Use of Cytomab 500 mg Injection is not recommended in patients with the active liver disease or those who had viral hepatitis as it can reactivate the infection.
